| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-09 |
| mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
5e-07 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |